Wed, May 27, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index Up 0.49% in April (+0.30 YTD)

Monday, May 14, 2018
Opalesque Industry Update - Hedge Funds gained 0.49% in April according to the Barclay Hedge Fund Index compiled by BarclayHedge, versus a 0.38% gain in the S&P 500 Total Return Index. Year to date, the Barclay Index remains up 0.30%, while the S&P has lost 0.38%.

"Increasing tension in the middle east and White House displeasure with the Iran nuclear deal provided a lift to share prices of energy companies," says Sol Waksman, founder and president of BarclayHedge.

Overall, 13 of Barclay's 17 hedge fund indices had gains in April. The Technology Index jumped 2.96%, European Equites were up 2.37%, Distressed Securities gained 1.17%, and the Equity Long/Short Index added 0.86%.

The Emerging Markets Index fell 0.94% in April, Merger Arbitrage lost 0.12%, and the Equity Market Neutral Index slipped 0.05%.

"A plummeting peso in Argentina, a strengthening US dollar, and a four-year high for US 10-year Treasury yields put downward pressure on emerging markets in April," says Waksman.

At the end of April, 10 hedge fund indices have gains for the year, and seven have losses. The Technology Index is up 5.93%, Healthcare & Biotechnology has gained 3.20%, Distressed Securities are up 2.44%, and European Equites have gained 2.17%.

Pacific Rim Equities have lost 2.54% year to date, Global Macro is down 1.46%, the Event Driven Index has lost 1.20%, and Merger Arbitrage is down 1.08%.

The Barclay Fund of Funds Index gained 0.34% in April, and has a year-to-date gain of 0.45%.

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Tiger Global tops the list US-based venture capital market[more]

    Laxman Pai, Opalesque Asia: Tiger Global Management holds on to its position as market-leader in US-based venture capital, said a study. According to Preqin, the closure of tech-focused Tiger Global Private Investment Partners XII in January means the New York-based firm has raised more than

  2. Tech: Fintech startup Brex closes $150m in pure venture funding amid recession[more]

    From Business Insider: Brex, the 3-year-old fintech unicorn, raised an additional $150 million in equity funding from existing investors and Lone Pine Capital, the company announced Tuesday. The cash infusion raised the startup's valuation to "around the $3 billion mark," cofounder and co-CEO Henriq

  3. PE/VC: Venture debt set to take prominent role, Building out Goldman Sachs's private-equity business[more]

    Venture debt set to take prominent role From PE News: Venture debt financing could be having its moment as the equity market becomes less friendly to start-ups. About $10bn worth of venture debt deals were made this year as of 21 April, a pace set to eclipse the roughly $25bn in such de

  4. Study: Emerging market bond issuers take hit as global recession deepens, The coronavirus pandemic could cost the global economy a nightmarish $82tn over 5 years, a Cambridge study warns[more]

    Emerging market bond issuers take hit as global recession deepens Increasing credit stress evident amongst many high-yield EM non-financial corporates as coronavirus disruption takes its toll, says Moody's. 74 out of 106 rated EM sovereigns have a stable outlook as of 30 April 2020 (compa

  5. Investing: Singer bets on Europe, emerging markets, Britain's unhealthy appetite for financial risk in essential services, How Stan Druckenmiller shook up his portfolio[more]

    Singer bets on Europe, emerging markets From Investment Magazine: William Blair's Brian Singer is looking to invest in Europe and the emerging markets as the recovery from the global economic shutdown to contain the pandemic will likely take longer than what the market has priced in.